ARTICLE | Clinical News
Celgene regulatory update
June 5, 1995 7:00 AM UTC
Celgene Corp. (CELG) The FDA granted Orphan Drug designation for Synovir, CELG's thalidomide compound, to treat recurrent aphthous ulcers (canker sores) in immunocompromised patients. Synovir also ha...